Physician profile
Hossein Ameri
NPI 1245467687
$27,432.07
in general payments reported to CMS, 2019-2025
11 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,018 · 2020: $5,925 · 2021: $9,426 · 2022: $4,176 · 2023: $259 · 2024: $512 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $887.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spark Therapeutics, INC. | $26,147.25 | 2019-2022 | |
| Alcon Vision LLC | $289.52 | 2019-2025 | Hydrus Microstent, Unity, Constellation |
| Novartis Pharmaceuticals Corporation | $249.98 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $220.07 | 2023 | Artevo 800 |
| Dutch Ophthalmic, USA | $174.51 | 2024 | Eva, Combined Machine, Tissueblue |
| Alimera Sciences, INC. | $127.07 | 2024 | Iluvien, Yutiq |
| Astellas Pharma US INC | $121.81 | 2024 | Izervay |
| Abbvie INC. | $61.97 | 2024 | |
| Genentech USA, INC. | $39.06 | 2023 | Vabysmo |
| Travere Therapeutics, INC. | $0.83 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hossein Ameri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.